Artificial intelligence - Hope for rare disease patients?

Rare or orphan diseases affect only a small percentage of the
population and often lack effective treatments. While rare
individually, in total, more than 350 million people worldwide live
with rare diseases. Many of these are very hard to diagnose, let
alone cure, and the rarity of patients challenges the development
of novel treatments. To make the development of drugs for rare
diseases more efficient and successful, artificial intelligence
could be an important ally not only for drug makers but also for
patients. In episode 24 of "We’re Doomed, We’re Saved," Andreas
Horchler and Louise von Stechow discuss the benefits and challenges
of using AI for drug development in rare diseases. Content and
Editing: Louise von Stechow and Andreas Horchler Disclaimer: Louise
von Stechow & Andreas Horchler and their guests express their
personal opinions, which are founded on research on the respective
topics, but do not claim to give medical, investment or even life
advice in the podcast. Learn more about the future of biotech in
our podcasts and keynotes. Contact us here: scientific
communication: https://science-tales.com/ Podcasts:
https://www.podcon.de/ Keynotes:
https://www.zukunftsinstitut.de/louise-von-stechow Image: Geranimo
via Unsplash